New chondrosarcoma cell lines and mouse models to study the link between chondrogenesis and chemoresistance

Mutations in the Isocitrate Dehydrogenase Genes IDH1 and IDH2 in Tumors

(2012) Frank G. Schaap et al.   ADVANCES IN ANATOMIC PATHOLOGY

Oncostatin M Is a Growth Factor for Ewing Sarcoma

(2012) Emmanuelle David et al.   AMERICAN JOURNAL OF PATHOLOGY

Three new chondrosarcoma cell lines: one grade III conventional central chondrosarcoma and two dedifferentiated chondrosarcomas of bone

(2012) Jolieke G van Oosterwijk et al.   BMC CANCER

Molecular alterations of isocitrate dehydrogenase 1 and 2 (IDH1 and IDH2) metabolic genes and additional genetic mutations in newly diagnosed acute myeloid leukemia patients

(2012) Sadudee Chotirat et al.   Journal of Hematology & Oncology

Characterization of a New Human Cell Line (CH-3573) Derived from a Grade II Chondrosarcoma with Matrix Production

(2012) Silvia Calabuig-Fariñas et al.   PATHOLOGY & ONCOLOGY RESEARCH

Identification of CBX3 and ABCA5 as Putative Biomarkers for Tumor Stem Cells in Osteosarcoma

(2012) Vaibhav Saini et al.   PLoS One

Induction of Osteogenesis in Mesenchymal Stem Cells by Activated Monocytes/Macrophages Depends on Oncostatin M Signaling

(2012) Pierre Guihard et al.   STEM CELLS

Restoration of chemosensitivity for doxorubicin and cisplatin in chondrosarcoma in vitro: BCL-2 family members cause chemoresistance

(2011) J. G. van Oosterwijk et al.   ANNALS OF ONCOLOGY

The antiapoptotic gene survivin is highly expressed in human chondrosarcoma and promotes drug resistance in chondrosarcoma cells in vitro

(2011) Philipp Lechler et al.   BMC CANCER

Quaternary ammonium-melphalan conjugate for anticancer therapy of chondrosarcoma: in vitro and in vivo preclinical studies

(2011) Caroline Peyrode et al.   INVESTIGATIONAL NEW DRUGS

IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours

(2011) M Fernanda Amary et al.   JOURNAL OF PATHOLOGY

Functional characterization of osteosarcoma cell lines provides representative models to study the human disease

(2011) Alexander B Mohseny et al.   LABORATORY INVESTIGATION

Somatic mosaic IDH1 and IDH2 mutations are associated with enchondroma and spindle cell hemangioma in Ollier disease and Maffucci syndrome

(2011) Twinkal C Pansuriya et al.   NATURE GENETICS

Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes

(2011) Yoko S DeRose et al.   NATURE MEDICINE

Mutations in TP53 are exclusively associated with del(17p) in multiple myeloma

(2010) L. Lode et al.   HAEMATOLOGICA

Short tandem repeat profiling: part of an overall strategy for reducing the frequency of cell misidentification

(2010) Raymond W. Nims et al.   IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL

Direct anti-cancer effect of oncostatin M on chondrosarcoma

(2010) Emmanuelle David et al.   INTERNATIONAL JOURNAL OF CANCER

Therapeutic molecular targets in human chondrosarcoma

(2010) Nuor Jamil et al.   INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY

Safety Concern between Autologous Fat Graft, Mesenchymal Stem Cell and Osteosarcoma Recurrence

(2010) Pierre Perrot et al.   PLoS One

Heterogeneity of angiogenesis and blood vessel maturation in cartilage tumors

(2009) Thomas Kalinski et al.   PATHOLOGY RESEARCH AND PRACTICE

Central chondrosarcoma progression is associated with pRb pathway alterations: CDK4 down-regulation and p16 overexpression inhibit cell growth in vitro

(2008) Yvonne M. Schrage et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

A chondrogenic gene expression signature in mesenchymal stem cells is a classifier of conventional central chondrosarcoma

(2008) S Boeuf et al.   JOURNAL OF PATHOLOGY

Defective activations of STAT3 Ser727 and PKC isoforms lead to oncostatin M resistance in metastatic melanoma cells

(2008) A. Lacreusette et al.   JOURNAL OF PATHOLOGY

The Clinical Approach Towards Chondrosarcoma

(2008) H. Gelderblom et al.   ONCOLOGIST